CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èµ¿Çö
  • ÇǺΰúÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °Ç¼±/ÇǺξÏ/»ö¼Ò¼ºÁúȯ/Å»¸ð/µÎÇÇÁúȯ
  • Á÷ À§: ±³¼ö(ÇǺΰúÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
125 (±¹³»)KCI ÇǺΰú·Î ÇùÁø ÀÇ·ÚµÈ ¼Ò¾Æû¼Ò³â°ú ÀÔ¿øȯÀÚÀÇ Áúȯº° Ư¼º¿¡ µû¸¥ °íÂû
124 (±¹¿Ü)SCIE Ultrasound-guided auriculotemporal nerve block for post-herpetic auriculotemporal neuropathy: A case report
123 (±¹¿Ü)SCIE Comparative study of buffered 50% glycolic acid (pH 3.0) + 0.5% salicylic acid solution vs Jessner's solution in patients with acne vulgaris
122 (±¹¿Ü)SCIE Comparative Study of Buffered 50% Glycolic Acid (pH 3.0) 0.5% Salicylic Acid Solution Versus Jessner¡¯s Solution in Patients with Acne Vulgaris
121 (±¹³»)KCI °Ç¼±È¯ÀÚ¿¡¼­ ¹ß»ýÇÑ ¹é¹ÝÁõ
120 (±¹³»)KCI ¾ÆÅäÇÇÇǺο°°ú º´¹ßÇÑ °Ç¼±
119 (±¹³»)KCI ¿ÜÀ½ºÎ¿¡ ¹ß»ýÇÑ À¯µÎ¸ð¾ç ¶¡°ü³¶»ùÁ¾
118 (±¹¿Ü)SCIE Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis
117 (±¹¿Ü)SCI Factors affecting the quality of life in patients with vitiligo: a nationwide study
116 (±¹³»)KCI ¹Î°¨¼º ÇǺÎ
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729